BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 30, 2026
Home
»
Topics
»
Science
» Drug design, drug delivery and technologies
Drug design, drug delivery and technologies
RSS
Synthesis and activity of potent, selective sigma1 ligands reported by Taisho
Oct. 8, 1999
Aventis R&T expands drug discovery collaboration with Nanogen
Oct. 5, 1999
Incyte and Schering expand agreement
Oct. 5, 1999
Isis and RPR establish collaboration for antisense target validation
Oct. 4, 1999
ImmGenics and Genzyme enter collaboration agreement to use SLAM technology
Oct. 4, 1999
Molecumetics and P&U enter collaboration for caspase research
Sep. 30, 1999
Medarex enters HuMAb-Mouse antibody agreement with Amgen
Sep. 28, 1999
Fournier synthesizes novel potent B2 agonists resistant to enzymatic degradation
Sep. 24, 1999
Bristol-Myers Squibb enters target validation collaboration with Exelixis
Sep. 23, 1999
M.D. Anderson Cancer Center and Cryogenic Solutions enter antisense collaboration
Sep. 22, 1999
Previous
1
2
…
308
309
310
311
312
313
314
315
316
…
412
413
Next